[Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
In order to determine the pituitary or ovarian site of the anti-gonadotrophic action of prolactin (PRL), ten women with hyperprolactinaemia were studied in the following way: 1) Repeated estimations of PRL, gonadotrophins (LH and FSH), plasma estradiol and progesterone during six weeks of treatment with bromocriptine. 2) Verification of the effects of estradiol benzoate on LH and FSH levels before and after normalisation of prolactin. 3) Exploration of the ovarian response to the administration of human menopausal gonadotrophin. Without it being possible to exclude any direct effect of prolactin on the ovary, it may be affirmed that the hormone decreases the sensitivity of the gonadotrophic cells to the positive feedback mechanism exerted by plasma estradiol.
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy / Q000209:etiology*; D001971:Bromocriptine / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005687:Galactorrhea / Q000188:drug therapy / Q000209:etiology*; D007987:Gonadotropin-Releasing Hormone; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors*; D006801:Humans; D007775:Lactation Disorders / Q000209:etiology*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008596:Menotropins; D010053:Ovary / Q000503:physiopathology; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood*
D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D011374:Progesterone; D004958:Estradiol; D008596:Menotropins; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Actions antigonadotropes de la prolactine. Etude de dix cas féminins d'hyperprolactinémie